Substance use & recovery

When Your Insurer Wants to End Treatment Early

Save

Mid-treatment denials arrive through a process called concurrent, or utilization, review. They feel final and they rarely are. Federal parity law limits how much harder a plan can be on addiction care than on medical care, and every plan owes you an appeal — internal first, then an independent external review. Here is what the denial actually means, what leaving early can cost, and the moves that keep care going.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does it mean when your insurer says the stay is ending?

A plan almost never authorizes an entire residential or inpatient stay up front. It approves care a few days at a time, then re-checks whether continued treatment still meets its criteria. That recurring re-check is concurrent review — also called utilization review. When the plan's reviewer decides the criteria for the current level of care are no longer met, the plan stops paying for days going forward. It usually does not claw back the days it already covered.

The judgment being made is about medical necessity: the reviewer, often a clinician working from the insurer's own criteria set, is deciding that you could safely step down to a less intensive level. That is a clinical opinion, formed without meeting you, and it is exactly the kind of opinion the appeals system exists to contest. Understanding how concurrent utilization review works is the first lever most families never realize they have.

Is a mid-treatment denial the final word?

No. A denial is the start of a process, not the end of one. Every plan is required to give you a way to challenge it, and the fastest of those is often a same-day phone call between your treating clinician and the insurer's reviewer. If that does not resolve it, a formal appeal follows.

  • Peer-to-peer review. Your clinician requests a direct conversation with the insurer's reviewing physician to argue that the criteria for continued care are still met. This is frequently the quickest way to overturn a concurrent review denial.
  • Internal appeal. A written request asking the plan to reconsider, usually with a clinical letter and records attached.
  • External review. If the internal appeal fails, most plans owe you an independent external review by a reviewer not employed by the insurer.

Each of these has deadlines, and expedited timelines exist when a delay would endanger health. The mechanics of a continued stay appeal, and how the internal appeal and external review fit together, are worth reading in full before the clock runs down.

What does parity law give you here?

Federal parity law is the strongest structural argument against a lopsided cut. The Mental Health Parity and Addiction Equity Act generally requires a plan that covers mental-health and substance-use benefits to apply no more restrictive treatment limits or review practices to them than it applies to comparable medical and surgical care 1. If a plan authorizes long stays for a medical condition but reflexively trims addiction stays, that asymmetry is what parity is meant to catch.

The law has a real limit, and honesty about it matters: parity does not force a plan to cover addiction treatment in the first place — it governs how a plan treats the benefit it already offers 1. So parity is not a guarantee of an approved stay. It is a standard you can hold the plan to when its behavioral-health review looks harsher than its medical review, and that comparison is often the core of a strong appeal.

Why leaving treatment early can be dangerous

A coverage decision and a clinical decision are not the same thing, and the gap between them can be dangerous. This is clearest with opioids. When someone completes withdrawal and their tolerance drops, returning to a previously ordinary amount can be fatal — a follow-up study found overdose deaths clustered in the period right after people left inpatient detox, precisely because tolerance had fallen 2. A stay ended before a person is stabilized and connected to ongoing care can leave them more exposed, not less.

For opioid use disorder specifically, the national treatment guideline holds that medication such as methadone or buprenorphine should not be arbitrarily time-limited, and that withdrawal management alone is not the recommended treatment 3. A denial letter does not overrule your clinician's judgment about what is safe. If the treatment team believes discharge now would be unsafe, that clinical position belongs in the appeal, and it is often the most persuasive thing in it.

What to ask your treatment team to do

The treatment team is your most important ally in a concurrent-review fight, because the appeal turns on clinical documentation only they can supply. Most programs handle utilization review daily and have staff whose job is exactly this. It is reasonable to ask them, plainly, to act quickly and to keep you informed.

  • Ask them to request a peer-to-peer review right away, before the authorized days run out.
  • Ask for the denial reason in writing, and for the specific medical-necessity criteria the plan says are no longer met.
  • Ask what clinical facts — ongoing withdrawal risk, a co-occurring condition, an unstable living situation — support continued care, and make sure those are documented.
  • Ask whether the program will keep providing care during the appeal, and what that means for the bill if the appeal fails.

These are administrative questions, not confrontations. A program that resists documenting its own clinical reasoning is itself a signal worth noting.

Does it work differently on Medicaid?

The appeal right exists on Medicaid too, and parity protections apply there as well. Parity requirements extend into Medicaid and CHIP, so a state Medicaid plan or its managed-care organization generally cannot impose stricter limits on behavioral-health care than on comparable medical care 4. The names and deadlines differ from commercial insurance — Medicaid appeals often run through a state fair-hearing process — but the underlying principle is the same: a denial can be challenged, and an independent review is available.

Because Medicaid managed-care plans also use concurrent review, the same early moves matter: get the denial reasoning in writing, ask the treatment team to pursue a peer-to-peer conversation, and file the appeal within the stated window. State Medicaid agencies publish their appeal and fair-hearing steps; those steps, not a phone agent's summary, are the authoritative account of your rights.

How do you pay while an appeal is pending?

This is the pressure the whole system runs on, and it is worth naming plainly. If care continues during an appeal and the appeal loses, you may owe for those days. If care stops, the clinical risk is real. There is no painless answer, but a few facts change the math. Understanding how insurance coverage for rehab works — deductibles, in-network versus out-of-network status, and what an appeal can and cannot recover — helps you weigh the decision instead of making it in a panic.

Some programs will negotiate a self-pay rate for continued days, or hold billing until the appeal resolves; it is reasonable to ask. What is rarely wise is treating the denial itself as a clinical instruction to leave. The insurer is deciding what it will pay for, not what is medically safe. Keeping those two questions separate — one for the appeals process, one for your treatment team — is the clearest way through a frightening week.

Common questions

It can stop paying for future days through concurrent review, which re-checks medical necessity every few days. It generally does not undo days already authorized. A decision to stop paying is not the same as a decision that leaving is medically safe, and it can be appealed — often quickly, through a peer-to-peer call between your clinician and the insurer.

A direct conversation between your treating clinician and the insurer's reviewing physician, in which your clinician argues that the criteria for continued care are still met. It is often the fastest way to overturn a mid-treatment denial, and treatment programs request them routinely. Asking the team to initiate one before the authorized days run out is usually the first step.

Quickly. Appeals carry deadlines, and the authorized days may be nearly gone when the denial arrives. Expedited appeals exist for situations where waiting would endanger health, and they run on much shorter timelines. Getting the denial reason in writing and asking the treatment team to start the appeal the same day gives you the most room.

No. Parity law requires a plan to apply no stricter limits to addiction care than to comparable medical care, but it does not force a plan to cover addiction treatment at all. It is a fairness standard, not a coverage guarantee. Its power in an appeal is the comparison: showing the plan reviews behavioral-health care more harshly than medical care.

That is a decision for you and your treatment team, not for the insurer. A coverage decision is about what the plan will pay, not about what is clinically safe. For opioid use disorder in particular, leaving before stabilization can raise overdose risk. Weigh the clinical picture and the appeal options together rather than treating the denial as a medical instruction.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When ending care early becomes a safety issue

  • An opioid overdose after any period of reduced use: slow or stopped breathing, blue or gray lips and fingertips, or a person who cannot be woken
  • Return of severe alcohol or benzodiazepine withdrawal after discharge — a seizure, or confusion, agitation, fever, and a racing heart
  • New or worsening thoughts of suicide in the days after an abrupt discharge
  • Being pressured to leave against your treatment team's documented clinical judgment

Call 911 for a suspected overdose or a withdrawal seizure, and give naloxone for a suspected opioid overdose. For thoughts of suicide, call or text 988. SAMHSA's National Helpline, 1-800-662-HELP, gives free, confidential treatment referrals 24/7.

This article is general health and coverage information, not medical or legal advice. Appeal rights, deadlines, and parity protections vary by plan and by state, and clinical decisions about continuing or ending treatment should be made with a licensed clinician who can assess the individual.

References

  1. 1.Centers for Medicare & Medicaid Services (2024). Mental Health Parity and Addiction Equity Act (MHPAEA). Centers for Medicare & Medicaid Services (CMS). linkUsed for the claim that MHPAEA generally bars a plan covering mental-health/substance-use benefits from applying more restrictive treatment limits or review practices than for comparable medical care, but does not itself require a plan to cover substance-use treatment.
  2. 2.Strang J, McCambridge J, Best D, et al. (2003). Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. doi:10.1136/bmj.326.7396.959Used for the claim that opioid detoxification lowers tolerance and that overdose deaths cluster in the period right after people leave inpatient detox, so ending care early can raise overdose risk.
  3. 3.American Society of Addiction Medicine (2020). The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update. American Society of Addiction Medicine (ASAM). linkUsed for the claim that the guideline holds medication for opioid use disorder should not be arbitrarily time-limited and that withdrawal management alone is not the recommended treatment.
  4. 4.Centers for Medicare & Medicaid Services / Medicaid.gov (2024). Parity — Behavioral Health Services. Medicaid.gov. linkUsed for the claim that parity requirements extend into Medicaid and CHIP, so a Medicaid plan generally cannot impose stricter limits on behavioral-health care than on comparable medical care.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy